Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
An epidemiological study of neuromyelitis optica in Isfahan.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation.
NMDA receptor antibodies associated with distinct white matter syndromes.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
The mechanism of effective electroacupuncture on T cell response in rats with experimental autoimmune encephalomyelitis.
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Clinical use of brain volumetry.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
Pages
« first
‹ previous
…
363
364
365
366
367
368
369
370
371
…
next ›
last »